rs201778566

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong

The NM_002458.3(MUC5B):​c.13751C>T​(p.Thr4584Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0198 in 150,794 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.027 ( 2 hom. )
Failed GnomAD Quality Control

Consequence

MUC5B
NM_002458.3 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.00800

Publications

4 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B Gene-Disease associations (from GenCC):
  • interstitial lung disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

PM2
Variant has high frequency in the NFE (0.0244) population. However there is too low homozygotes in high coverage region: (expected more than 14, got 1).
BP4
Computational evidence support a benign effect (MetaRNN=0.0036872923).
BP6
Variant 11-1250631-C-T is Benign according to our data. Variant chr11-1250631-C-T is described in ClinVar as [Benign]. Clinvar id is 403177.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.13751C>T p.Thr4584Ile missense_variant Exon 31 of 49 ENST00000529681.5 NP_002449.2 Q9HC84

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.13751C>T p.Thr4584Ile missense_variant Exon 31 of 49 5 NM_002458.3 ENSP00000436812.1 Q9HC84

Frequencies

GnomAD3 genomes
AF:
0.0199
AC:
2991
AN:
150674
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0118
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00630
Gnomad ASJ
AF:
0.0207
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00666
Gnomad FIN
AF:
0.0545
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0254
Gnomad OTH
AF:
0.0178
GnomAD2 exomes
AF:
0.0227
AC:
5588
AN:
246662
AF XY:
0.0228
show subpopulations
Gnomad AFR exome
AF:
0.0121
Gnomad AMR exome
AF:
0.00404
Gnomad ASJ exome
AF:
0.0254
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0676
Gnomad NFE exome
AF:
0.0288
Gnomad OTH exome
AF:
0.0218
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0270
AC:
39228
AN:
1453506
Hom.:
2
Cov.:
151
AF XY:
0.0263
AC XY:
19036
AN XY:
722996
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0113
AC:
379
AN:
33416
American (AMR)
AF:
0.00464
AC:
207
AN:
44622
Ashkenazi Jewish (ASJ)
AF:
0.0255
AC:
661
AN:
25948
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00834
AC:
718
AN:
86078
European-Finnish (FIN)
AF:
0.0618
AC:
3232
AN:
52314
Middle Eastern (MID)
AF:
0.00469
AC:
27
AN:
5754
European-Non Finnish (NFE)
AF:
0.0295
AC:
32566
AN:
1105680
Other (OTH)
AF:
0.0240
AC:
1438
AN:
59994
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.282
Heterozygous variant carriers
0
3676
7352
11028
14704
18380
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1238
2476
3714
4952
6190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0198
AC:
2991
AN:
150794
Hom.:
1
Cov.:
32
AF XY:
0.0199
AC XY:
1466
AN XY:
73656
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0117
AC:
486
AN:
41402
American (AMR)
AF:
0.00630
AC:
96
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.0207
AC:
71
AN:
3430
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5166
South Asian (SAS)
AF:
0.00687
AC:
33
AN:
4802
European-Finnish (FIN)
AF:
0.0545
AC:
564
AN:
10342
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0254
AC:
1703
AN:
67102
Other (OTH)
AF:
0.0177
AC:
37
AN:
2096
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.331
Heterozygous variant carriers
0
154
309
463
618
772
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0286
Hom.:
1
ExAC
AF:
0.0259
AC:
3129

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
6.6
DANN
Benign
0.87
DEOGEN2
Benign
0.025
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.0053
N
LIST_S2
Benign
0.45
T
MetaRNN
Benign
0.0037
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.8
L
PhyloP100
0.0080
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.69
N
REVEL
Benign
0.015
Sift
Uncertain
0.024
D
Vest4
0.041
ClinPred
0.0012
T
GERP RS
-1.7
Varity_R
0.033
gMVP
0.17
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201778566; hg19: chr11-1271861; COSMIC: COSV71594223; COSMIC: COSV71594223; API